AAIC 2015: Approved drug combo cuts Alzheimer’s disease agitation

WASHINGTON – Daily treatment with a combined formulation of dextromethorphan and quinidine led to a significant and clinically meaningful cut in agitation episodes among patients with Alzheimer’s...